Cellula Therapeutics was founded in July 2023 as a venture of Remora Biotech, a successful Lausanne based VC group with ventures spread in France and Switzerland focuses in Biotech value creation ventures.

When breakthrough ideas encounter industry leaders, renown scientists and leading entrepreneurs focused in delivering therapeutic solutions to cure cancer nothing is impossible!

Cellula is incepted by world class innovation in CAR-T cell research, from scientific a team trained at University of Pennsylvania in Philadelphia US, with breakthrough inventions in T cells established at University of Geneva, at Agora research centre in and Lausanne Biopole in Switzerland. The research team lead by professor Denis Migliorini has uncovered brand new pathways of arming immune cell effectors to address the challenges of solid tumours and in specific of brain Tumours.

A founding team of visionary industry executives in Cell and Gene therapy, seasoned Biotech Leaders and Entrepreneurs has given rise to Cellula Therapeutics, a value creating enterprise located at Lausanne Biopole incubator!